SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Martel-Pelletier J, Boileau C, Pelletier JP, Roughley PJ. Cartilage in normal and osteoarthritis conditions. Best Pract Res Clin Rheumatol 2008; 22: 35184.
  • 2
    Hughes SL, Dunlop D. The prevalence and impact of arthritis in older persons. Arthritis Care Res 1995; 8: 25764.
  • 3
    Mirrolla M. The cost of chronic disease in Canada. Ottawa: Chronic Disease Prevention Alliance of Canada; 2004.
  • 4
    Zhang Y, Jordan JM. Epidemiology of osteoarthritis. Clin Geriatr Med 2010; 26: 35569.
  • 5
    Hootman J, Bolen J, Helmick C, Langmaid G. Prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation: United States, 2003-2005. MMWR Morb Mortal Wkly Rep 2006; 55: 1129.
  • 6
    Glazier RH, Badley EM, Wright JG, Coyte PC, Williams JI, Harvey B, et al. Patient and provider factors related to comprehensive arthritis care in a community setting in Ontario, Canada. J Rheumatol 2003; 30: 184650.
  • 7
    Grindrod KA, Marra CA, Colley L, Cibere J, Tsuyuki RT, Esdaile JM, et al. After patients are diagnosed with knee osteoarthritis, what do they do? Arthritis Care Res (Hoboken) 2010; 62: 5105.
  • 8
    Ganz DA, Chang JT, Roth CP, Guan M, Kamberg CJ, Niu F, et al. Quality of osteoarthritis care for community-dwelling older adults. Arthritis Rheum 2006; 55: 2417.
  • 9
    Hochberg MC, Altman RD, Brandt KD, Clark BM, Dieppe PA, Griffin MR, et al. Guidelines for the medical management of osteoarthritis. Part II. Osteoarthritis of the knee. Arthritis Rheum 1995; 38: 15416.
  • 10
    Lane NE, Thompson JM. Management of osteoarthritis in the primary-care setting: an evidence-based approach to treatment. Am J Med 1997; 103: 25S30S.
  • 11
    Pencharz JN, MacLean CH. Measuring quality in arthritis care: the Arthritis Foundation's quality indicator set for osteoarthritis. Arthritis Rheum 2004; 51: 53848.
  • 12
    MacLean CH. Quality indicators for the management of osteoarthritis in vulnerable elders. Ann Intern Med 2001; 135: 71121.
  • 13
    Porcheret M, Jordan K, Croft P, and the Primary Care Rheumatology Society. Treatment of knee pain in older adults in primary care: development of an evidence-based model of care. Rheumatology (Oxford) 2007; 46: 63848.
  • 14
    Padiyara RS, D'Souza JJ, Rihani RS. Clinical pharmacist intervention and the proportion of diabetes patients attaining prevention objectives in a multispecialty medical group. J Manag Care Pharm 2011; 17: 45662.
  • 15
    Marra CA, Tsuyuki RT, Soon JA, Gastonguay L, Oteng B, Cibere J, et al. Design of a randomized trial of a multidisciplinary intervention for knee osteoarthritis: pharmacist initiated intervention trial in osteoarthritis (PhIT-OA). CPJ 2008; 141: 339.
  • 16
    Hay EM, Foster NE, Thomas E, Peat G, Phelan M, Yates HE, et al. Effectiveness of community physiotherapy and enhanced pharmacy review for knee pain in people aged over 55 presenting to primary care: pragmatic randomised trial. BMJ 2006; 333: 995.
  • 17
    The Arthritis Society. Arthritis Self-Management Program. URL: http://www.arthritis.ca/asmp.
  • 18
    American College of Sports Medicine. URL: http://www.acsm.org.
  • 19
    Karvonen MJ, Kentala E, Mustala O. The effects of training on heart rate: a longitudinal study. Ann Med Exp Biol Fenn 1957; 35: 30715.
  • 20
    Zingmond DS, Wilber KH, Maclean CH, Wenger NS. Measuring the quality of care provided to community dwelling vulnerable elders dually enrolled in Medicare and Medicaid. Med Care 2007; 45: 9318.
  • 21
    Bellamy N. WOMAC: a 20-year experiential review of a patient-centered self-reported health status questionnaire. J Rheumatol 2002; 29: 24736.
  • 22
    Binkley JM, Stratford PW, Lott SA, Riddle DL, for the North American Orthopaedic Rehabilitation Research Network. The Lower Extremity Functional Scale (LEFS): scale development, measurement properties, and clinical application. Phys Ther 1999; 79: 37183.
  • 23
    Feeny D, Wu L, Eng K. Comparing Short Form 6D, Standard Gamble, and Health Utilities Index Mark 2 and Mark 3 utility scores: results from total hip arthroplasty patients. Qual Life Res 2004; 13: 165970.
  • 24
    Grootendorst P, Marshall D, Pericak D, Bellamy N, Feeny D, Torrance GW. A model to estimate Health Utilities Index Mark 3 utility scores from WOMAC index scores in patients with osteoarthritis of the knee. J Rheumatol 2007; 34: 53442.
  • 25
    Kopec JA, Badii M, McKenna M, Lima VD, Sayre EC, Dvorak M. Computerized adaptive testing in back pain: validation of the CAT-5D-QOL. Spine (Phila Pa 1976) 2008; 33: 138490.
  • 26
    Kopec JA, Sayre EC, Davis AM, Badley EM, Abrahamowicz M, Sherlock L, et al. Assessment of health-related quality of life in arthritis: conceptualization and development of five item banks using item response theory. Health Qual Life Outcomes 2006; 4: 33.
  • 27
    Marshall D, Pericak D, Grootendorst P, Gooch K, Faris P, Frank C, et al. Validation of a prediction model to estimate Health Utilities Index Mark 3 utility scores from WOMAC index scores in patients with osteoarthritis of the hip. Value Health 2008; 11: 4707.
  • 28
    Marra CA, Cibere J, Tsuyuki RT, Soon JA, Esdaile JM, Gastonguay L, et al. Improving osteoarthritis detection in the community: pharmacist identification of new, diagnostically confirmed osteoarthritis. Arthritis Rheum 2007; 57: 123844.
  • 29
    MacLean CH, Saag KG, Solomon DH, Morton SC, Sampsel S, Klippel JH. Measuring quality in arthritis care: methods for developing the Arthritis Foundation's quality indicator set. Arthritis Rheum 2004; 51: 193202.
  • 30
    Blanchard C, Feeny D, Mahon JL, Bourne R, Rorabeck C, Stitt L, et al. Is the Health Utilities Index responsive in total hip arthroplasty patients? J Clin Epidemiol 2003; 56: 104654.
  • 31
    Health Canada. Arthritis in Canada. Ottawa: Health Canada; 2003.
  • 32
    Torrance GW, Raynauld JP, Walker V, Goldsmith CH, Bellamy N, Band PA, et al. A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (part 2 of 2): economic results. Osteoarthritis Cartilage 2002; 10: 51827.
  • 33
    Cvijovic K, Boon H, Jaeger W, Vohra S Pharmacists' participation in research: a case of trying to find the time. Int J Pharm Pract 2010; 18: 37783.